Pro-inflammatory biomarkers in decompensated and stable HFpEF patients

Slides:

Advertisements

Similar presentations

CLINICAL QUESTION By: Resident Name. 25 y/o male w/ hx of ___, ____, and ____, who presented w/ _______ found to have ________ admitted for ______ and.

Advertisements

Peter R. McNally, DO, FACP, FACG Lone Tree, Colorado

Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Understanding the Heterogeneity in Volume Overload.

CoRPS Center of Research on Psychology in Somatic diseases Inflammation, Mediation and Type D personality Multiple inflammatory biomarkers as mediators.

Effect of Phosphodiesterase-5 Inhibition on Exercise

David M Kaye MD, PhD on behalf of the REDUCE LAP HF Investigators

The Power of New Biomarkers to Detect Early Ischemia

Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),

Elevated Circulating Levels of Inflammatory Markers in

by Qi Sun, Monik C. Jiménez, Mary K. Townsend, Eric B. Rimm, JoAnn E

Left Ventricular Dysfunction With Pulmonary Hypertension

Current and future paradigm for prognostication and testing of therapeutics in patients with heart failure using machine learning. Current and future paradigm.

Volume 153, Issue 3, Pages e7 (September 2017)

Clyde W. Yancy et al. JACC 2017;70:

The Utility of Biomarkers in Sorting Out the Complex Patient

Figure 1 Energy supply–demand matching in health and heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Volume 153, Issue 3, Pages e7 (September 2017)

Evaluation of tumor necrosis factor-α, interleukin-6 and C-reactive protein plasma levels as predictors of bacteremia in patients presenting signs of.

Volume 80, Issue 11, Pages (December 2011)

Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease

Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Expert Insights on Complex Clinical Cases of Edema

Figure 4 Prevalence of HFpEF and HFrEF by age

Nat. Rev. Cardiol. doi: /nrcardio

Regarding “Prospective evaluation of postimplantation syndrome evolution on patient outcomes after endovascular aneurysm repair for abdominal aortic aneurysm”

OR (95% CI) for CHD associated with inflammatory markers before and after adjustment for established risk factors. OR (95% CI) for CHD associated with.

Nat. Rev. Cardiol. doi: /nrcardio

TACTICS-HF Trial design: Patients with acute heart failure (reduced or preserved ejection fraction) were randomized to tolvaptan 30 mg at 0, 24, and 48.

Effect of Ma-Pi diet versus control diet on change in TNF-α, IL-6, CRP, BAP test, and IGF-1. Effect of Ma-Pi diet versus control diet on change in TNF-α,

Receiver operator characteristic (ROC) curve analysis of the plasma biomarker panels for differentiating ARDS (cases) from controls in patients with severe.

Hypothesised conceptual framework of the association between lung and vascular events. Hypothesised conceptual framework of the association between lung.

OR (95% CI) for CHD associated with inflammatory markers in all participants and in subsets of non-users of statins or non-users of aspirin therapy. OR.

Unstimulated levels of soluble mediators from in cultures of individuals with and without T2D with periodontitis. Unstimulated levels of soluble mediators.

Figure 3 Responder subset (A) Percentage of “responders” (nonprogressing patients) at week 25 after 6 months of treatment; percentage of “responders” in.

(A–C) Time-course changes in morning time fasted, and daytime (A) IL-6, (B) TNF-α, and (C) β-hydroxybutyrate concentrations. (A–C) Time-course changes.

Romain Gallet et al. BTS 2016;1:14-28

Correlation of change in H2 concentration (△H2) haemodynamics or laboratory parameters. Correlation of change in H2 concentration (△H2) haemodynamics or.

Immune reconstitution inflammatory syndrome (IRIS) associated with Mycobacterium tuberculosis (TB) infection. a) In healthy individuals in response to.

Receiver operating characteristic curves for the association of primary outcome using each clinical risk score and each clinical risk score adjusted for.

Cumulative survival without events during 1 year in patients with preserved systolic function (left ventricular ejection fraction (LVEF) >40%) and with.

Figure 5 ADP-induced inflammatory responses require P2Y12 receptors in human microgliaIncreasing concentrations of ADP (5, 50, and 200 μM) increased tumor.

(A) Serum CRP levels. (A) Serum CRP levels. T2DM: n=6 per group. *p

Monitoring the induction of pro-inflammatory mediators and toll-like receptors (TLRs) following inhalation of AZD8848. Monitoring the induction of pro-inflammatory.

Volume 80, Issue 11, Pages (December 2011)

Figure 2. Odds ratios (ORs) from the multivariate logistic regression analysis and hazard ratios (HRs) from the Cox regression analysis Odds ratios (ORs)

Simpson's biplane ejection fraction (A), and two-dimensional speckle-tracking global longitudinal strain (B) in patients receiving clozapine treatment,

Supplementary Figure 4. Kaplan-Meier curves of 12-month readmission free survival rates according to renal dysfunction with subclassification in all (A),

Figure 3. Survival rates according to renal dysfunction

Volume 74, Issue 6, Pages (September 2008)

Average left ventricular ejection fraction (LVEF) values during the 1 year of observation in patients with preserved systolic function (LVEF >40%) and.

Steven R. Steinhubl, and Eric J. Topol JACC 2015;66:

Lifetime heart failure risk*

Kevin R. King et al. BTS 2016;1:73-86

Percentage distribution of ESC HF subtypes and no cardiac dysfunction (no dysf, n=38) among all 370 included patients, where HFvhd is HF due to valvular.

Survival curves according to the presence of late gadolinium enhancement (LGE) and elevated high-sensitivity C reactive protein (hs-CRP). Survival curves.

Algorithm for haemodynamic evaluation in the elderly.

Thomas A. Dewland et al. JACEP 2015;1:

Linear associations of specific FFAs with inflammatory biomarkers.

This figure provides a graphical overview of the data collection process as it was designed for the EFFECTOR study. BIA, bioelectrical impedance analysis;

Baseline characteristics of the participants according to study group.

Faecal metabolomics changed after the intervention.

Constantijn Franssen et al. JCHF 2016;4:

Adjusted cumulative incidence of stroke, by sex and heart failure status. Adjusted cumulative incidence of stroke, by sex and heart failure status. The.

Biomarker levels at hospital admission, clinical stabilisation and 6-week follow-up in 267 hospitalised patients with community-acquired pneumonia. a)

Temporal profiles of C-reactive protein (CRP), interleukin 6 (IL-6) and interleukin 1 receptor antagonist (IL-1Ra) after subarachnoid hemorrhage plotted.

Adjusted cumulative disability incidence by sex and heart failure status. Adjusted cumulative disability incidence by sex and heart failure status. The.

Cardioprotective effects of ivabradine administration in the setting of acute coronary syndromes and myocardial infarction. Cardioprotective effects of.

Presentation transcript:

Pro-inflammatory biomarkers in decompensated and stable HFpEF patients A post-hoc analysis of the RELAX, DOSE, and ROSE studies HFpEF: heart failure with preserved ejection fraction; RELAX: Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure with Preserved Ejection Fraction; DOSE: Diuretic Strategies in Patients With Acute Decompensated Heart Failure; ROSE: Renal Optimization Strategies Evaluation; IL-6: interleukin 6; TNF-a: tumor necrosis factor-a; hs-CRP: high sensitivity C-reactive protein; PTX3: pentraxin 3; Abernethy et al. JAMA 2018